Atlas Trials

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

Clinical trial NCT02195635 · COMPLETED

Trial details

NCT number
NCT02195635
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Interactions
Start date
2014-07-01
Primary completion
2014-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.